Microsoft word - oxford endocrinology masterclass programme year 2.doc
OXFORD ENDOCRINOLOGY MASTERCLASS OXFORD CENTRE FOR DIABETES, ENDOCRINOLOGY AND METABOLISM DISORDERS OF GROWTH AND DEVELOPMENT, THYROID GLAND, APPETITE AND WEIGHT, METABOLISM 12TH-13TH SEPTEMBER 2013 ST CATHERINE’S COLLEGE, OXFORD PROGRAMME THURSDAY 12TH SEPTEMBER 2013 9.15-9.45 Registration and Coffee 9.45-10.00 WELCOME AND MEETING OBJECTIVES 10.00-10.30 METHODS OF ASSESSMENT OF NORMAL GROWTH – GROWTH CHARTS Dr. Lynn Ahmed, Clinical Auxologist Oxford Children’s Hospital, Oxford University Hospitals NHS Trust 10.30-11.15 HYPOPITUITARISM IN CHILDHOOD: DIAGNOSIS AND MANAGEMENT Dr. Fiona Ryan, Consultant in Paediatric Endocrinology and Diabetes Oxford Children’s Hospital, Oxford University Hospitals NHS Trust 11.15-11.30 Coffee break 11.30-12.00 OBESITY: MEDICAL MANAGEMENT Prof. Nick Finer, Consultant Endocrinologist and Bariatric Physician UCLH Centre for Weight Loss, Metabolic and Endocrine Surgery University College London Hospitals 12.00-12.30 TRANSITION OF THE PAEDIATRIC ENDOCRINE PATIENT: WHAT THE ADULT ENDOCRINOLOGIST NEEDS TO KNOW Dr. Helena Gleeson, Consultant Endocrinologist Department of Diabetes and Endocrinology Leicester Royal Infirmary 12.30-14.00 Lunch break 14.00-14.30 THYROID FUNCTION TESTS: ASSAYS, PITFALLS Dr. Mark Gurnell, University Lecturer & Honorary Consultant Physician Metabolic Research Laboratories, University of Cambridge 14.30-15.00 IMAGING OF THE THYROID: WHAT THE ENDOCRINOLOGIST NEEDS TO KNOW Dr. Kevin Bradley, Consultant Radiologist Radiology Department, Oxford University Hospitals NHS Trust 15.00-15.30 Coffee break 15.30-16.00 HYPOTHYROIDISM: LEVOTHYROXINE, TRIIODOTHYRONINE ARMOUR THYROID? Prof. Colin Dayan, Professor of Clinical Diabetes and Metabolism Institute of Molecular and Experimental Medicine Cardiff University School of Medicine 16.00-16.30 SUBCLINICAL THYROID DISEASE Dr. Mark Vanderpump, Consultant Physician & Honorary Senior Lecturer in Diabetes and Endocrinology Royal Free London NHS Foundation Trust 16.30-17.15 PLENARY LECTURE: THYROID EYE DISEASE Prof. Wilmar Wiersinga, Emeritus Professor of Endocrinology University of Amsterdam, The Netherlands 17.15-17.20 19.00-21.00 FRIDAY 13TH SEPTEMBER 2013 9.30-10.00 AMIODARONE-INDUCED THYROID DISEASE Prof. Wilmar Wiersinga, Emeritus Professor of Endocrinology University of Amsterdam, The Netherlands 10.00-10.30 THYROID NODULES: MANAGEMENT AND INTERPRETATION OF FNA RESULTS Mr. Radu Mihai, Consultant Endocrine Surgeon Department of Surgery, Oxford University Hospitals NHS Trust 10.30-11.00 THYROID FUNCTION AND DISORDERS DURING PREGNANCY Dr. Oier Ateka, Locum Consultant Obstetric Physician Women’s Centre, Oxford University Hospitals NHS Trust 11.00-11.30 Coffee break 11.30-12.00 CHALLENGING CASES OF MEDULLARY THYROID CANCER Prof. Gregory Kaltsas, Consultant Endocrinologist Medical School, National University of Athens, Greece 12.00-12.45 CHALLENGING CASES OF FOLLICULAR THYROID CANCER Dr. Kate Newbold, Consultant Clinical Oncologist, The Royal Marsden NHS Foundation Trust 12.45-14.00 14.00-14.30 RADIOACTIVE IODINE FOR BENIGN THYROID DISEASE Dr. Niki Karavitaki, Consultant Endocrinologist & Honorary Senior Lecturer in Endocrinology Oxford Centre for Diabetes, Endocrinology and Metabolism University of Oxford & Oxford University Hospitals NHS Trust 14.30-15.00 HYPONATRAEMIA: INVESTIGATION AND MANAGEMENT Prof. Ashley Grossman, Professor of Endocrinology Oxford Centre for Diabetes, Endocrinology and Metabolism University of Oxford & Oxford University Hospitals NHS Trust 15.00-15.30 Coffee break 15.30-16.00 HYPOKALAEMIA: INVESTIGATION AND MANAGEMENT Prof. Ashley Grossman, Professor of Endocrinology Oxford Centre for Diabetes, Endocrinology and Metabolism University of Oxford & Oxford University Hospitals NHS Trust 16.00-16.30 OBESITY: SURGICAL MANAGEMENT Mr. Bruno Sgromo, Consultant Bariatric Surgeon Department of Surgery, Oxford University Hospitals NHS Trust
ABLE® C Electroporation-Competent Cells Catalog #200161 ABLE® C electroporation-competent cells (red-orange tubes) pUC18 control plasmid (0.1 ng/µl in TE buffer) Storage: Transfer the cells directly from the dry ice shipping container to the bottom of a –80°C freezer. Do not store cells in liquid nitrogen. QUALITY CONTROL TESTING Transformations are performed both with and without plasmi
European Journal of Neurology 2011, 18: 1115–1121E F N S G U I D E L I N E S / C M E A R T I C L ETreatment of medication overuse headache – guideline of theEFNS headache panelS. Eversa and R. JensenbaDepartment of Neurology, University of Mu¨nster, Mu¨nster, Germany; and bDanish Headache Center, Department of Neurology, GlostrupHospital, University of Copenhagen, Copenhagen, DenmarkBack
OXFORD ENDOCRINOLOGY MASTERCLASS 
Oxford Centre for Diabetes, Endocrinology and Metabolism